Transdermal clonidine in the treatment of severe hyperemesis. A pilot randomised control trial: CLONEMESI

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 121, Issue 12, 2014, Pages 1556-1562

  Maina, A ^a   Arrotta, M ^a   Cicogna, L ^a   Donvito, V ^a   Mischinelli, M ^b   Todros, T ^b   Rivolo, S ^c  

^a CITTÀ DELLA SALUTE E DELLA SCIENZA HOSPITAL   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Hyperemesis gravidarum; Randomised control trial; Transdermal clonidine; Treatment

Indexed keywords

ANTIEMETIC AGENT; CLONIDINE; PLACEBO; THIAMINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEPRESSED BLOOD PRESSURE; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DIZZINESS; DOUBLE BLIND PROCEDURE; DROWSINESS; FAINTNESS; FEMALE; GESTATIONAL AGE; HEADACHE; HUMAN; HYPEREMESIS GRAVIDARUM; KETONURIA; LASSITUDE; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; SKIN DISEASE; SYSTOLIC BLOOD PRESSURE; TERTIARY CARE CENTER; TREATMENT DURATION; VISUAL ANALOG SCALE; VITAMIN SUPPLEMENTATION; XEROSTOMIA; DRUG ADMINISTRATION; INTRADERMAL DRUG ADMINISTRATION; PREGNANCY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; ADULT; ANTIEMETICS; CLONIDINE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; HYPEREMESIS GRAVIDARUM; PILOT PROJECTS; PREGNANCY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84914666524     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/1471-0528.12757     Document Type: Article

References (28)

1. Niebyl JR Nausea and vomiting in pregnancy. N Engl J Med 2010; 363: 1544-55.
2. Jarvis S, Nelson-Piercy C. Management of nausea and vomiting in pregnancy. BMJ 2011; 342: 1407-12.
3. Jueckerstock JK, Kaestner R, Mylonas I. Managing hyperemesis gravidarum: a multimodal approach. BMC Med 2010; 8: 46.
4. Matthews A, Dowswell T, Haas DM, Doyle M, O'Mathuna DP. Interventions for nausea and vomiting in early pregnancy. Cochrane Database Syst Rev 2010: CD007575.
5. Nelson-Piercy C, Fayers P, de Swiet M. Randomised, double-blind, placebo-controlled trial of corticosteroids for the treatment of hyperemesis gravidarum. BJOG 2001; 108: 9-15.
6. Bolin M, Akerud H, Cnattingius S, Stephansson O, Wikstrom A. Hyperemesis gravidarum and risks of placental dysfunction disorders: a population-based cohort study. BJOG 2013; 120: 541-7.
7. Bailit JL Hyperemesis gravidarum: epidemiologic findings from a large cohort. Am J Obstet Gynecol 2005; 193: 811-4.
8. Veenendaal MV, Van Abeelen AF, Painter RC, van der Post JA, Roseboom TJ. Consequences of hyperemesis gravidarum for offspring: a systematic review and meta-analysis. BJOG 2011; 118: 1302-13.
9. Roseboom TJ, Ravelli AC, van der Post JA, Painter RC. Maternal characteristics largely explain poor pregnancy outcome after hyperemesis gravidarum. Eur J Obstet Gynecol Reprod Biol 2011; 156: 56-9.
10. Gross S, Librach C, Cecutti A. Maternal weight loss associated with hyperemesis gravidarum: a predictor of fetal outcome. Am J Obstet Gynecol 1989; 160: 906-9.
11. Maina A, Todros T. A novel approach to hyperemesis gravidarum: evaluation by a VAS score and treatment with transdermal clonidine. Obst Med 2011; 4: 156-9.
12. Kenward MG, Jones B. The analysis of data from 2 9 2 cross-over trials with baseline measurements. Stat Med 1987; 6: 911-26.
13. Koren G, Boskovic R, Hard M, Maltepe C, Navioz Y, Einarson A. Motherisk PUQE scoring system for nausea and vomiting of pregnancy. Am J Obst Gynecol 2002; 186:S229-31.
14. Koren G, Piwko C, Ahn E, Boskovic R, Maltepe C, Einarson A. Validation studies of Pregnancy Unique-Quantification of Emesis (PUQE) scores. J Obstetr Gynecol 2005; 25: 241-4.
15. Wijeysundera DN, Bender JS, Beattie WS. Alpha-2 adrenergic agonists for the prevention of cardiac complications among patients undergoing surgery. Cochrane Database Syst Rev 2009: CD00412.
16. Wallet F, Clement HJ, Bouret C, Lopez F, Broisin F, Pignal C, et al. Effects of a continuous low-dose clonidine epidural regimen on pain, satisfaction and adverse events during labour: a randomized, double-blind, placebo-controlled trial. Eur J Anaesthesiol 2010; 27: 441-7.
17. Gold MS, Redmond DE Jr, Kleber HD. Clonidine blocks acute opiate-withdrawal symptoms. Lancet 1978; ii: 599-602.
18. Tourette's Syndrome Study Group. Treatment of ADHD in children with tics: a randomized controlled trial. Neurology 2002; 58: 527-36.
19. Loprinzi CL, Barton DL, Sloan JA, Novotni PJ, Dakhil SR, Verdirame JD, et al. Mayo Clinic and North Central Cancer Treatment Group hot flash studies: a 20-year experience. Menopause 2008; 15: 655-60.
20. Handa F, Fujii Y. The efficacy of oral clonidine premedication in the prevention of postoperative vomiting in children following strabismus surgery. Paediatr Anaesth 2001; 11: 71-4.
21. Oddby-Muhrbeck E, Eksborg S, Bergendahl HT, Muhrbeck O, Lönnqvist PA. Effects of clonidine on postoperative nausea and vomiting in breast cancer surgery. Anesthesiology 2002; 96: 1109-14.
22. Taheri A, Javadimanesh MA, Ashraf H. The effect of oral clonidine premedication on nausea and vomiting after ear surgery. Middle East J Anesthesiol 2010; 20: 691.
23. Robichaud A, Savoie C, Stamatiou PB, Tattersall FD, Chan CC. PDE4 inhibitors induce emesis in ferrets via a noradrenergic pathway. Neuropharmacology 2001; 40: 262-9.
24. Regunathan S, Reis DJ. Imidazoline receptors and their endogenous ligands. Annu Rev Pharmacol Toxicol 1996; 36: 511-44.
25. Maze M, Tranquilli W. Alpha-2 adrenoceptor agonists: defining the role in clinical anesthesia. Anesthesiology 1991; 7: 581-6.
26. Buchanan ML, Easterling TR, Carr DB, Shen DD, Risler LJ, Nelson WL, et al. Clonidine pharmacokinetics in pregnancy. Drug Metab Dispos 2009; 37: 702-5.
27. Claessens AJ, Risler LJ, Eyal S, Shen DD, Easterling TR, Hebert MF. CYP2D6 mediates 4-hydroxylation of clonidine in vitro: implication for pregnancy-induced changes in clonidine clearance. Drug Metab Dispos 2010; 38: 1393-6.
28. Rothberger S, Carr D, Brateng D, Hebert M, Easterling TR. Pharmacodynamics of clonidine therapy in pregnancy: a heterogeneous maternal response impacts fetal growth. Am J Hypertens 2010; 23: 1234-40.